Baclofen
Back to searchMolecule Structure
Scientific Name
Baclofen
Description of the Drug
Baclofen is a GABA-ergic agonist used to manage severe spasticity of cerebral or spinal origin in adult and pediatric patients.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00181
http://www.drugbank.ca/drugs/DB00181
Brand Name(s)
Baclofen, Baclospas-10, Fleqsuvy, Gablofen, Kemstro, Lioresal, Lioresal intrath, Lyflex, Lyvispah, Ozobax
Company Owner(s)
Kartha Pharmaceuticals Inc, Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Mankind Pharma Ltd, Mylan Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Amneal Pharmaceuticals Llc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Impax Laboratories Inc, Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-B receptor | PROTEIN COMPLEX | AGONIST | CHEMBL2111463 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL19333 | |||
| PharmGKB | PA448533 | |||
| Human Metabolome Database | HMDB0014327 | |||
| DrugBank | DB00181 | |||
| PubChem: Thomson Pharma | 15195799 | |||
| PubChem | 2284 | |||
| Mcule | MCULE-2275748923 | |||
| LINCS | LSM-5169 | |||
| Nikkaji | J3.661G | |||
| BindingDB | 24182 | |||
| EPA CompTox Dashboard | DTXSID5022641 | |||
| DrugCentral | 282 | |||
| Brenda | 20134 | |||
| ChemicalBook | CB8669450 | |||
| Guide to Pharmacology | 1084 | |||
| rxnorm | OZOBAX | BACLOFEN | GABLOFEN | LIORESAL |
| ChEBI | 2972 | 187893 |
